Serious Adverse Event | Severe Adverse Event | CTCAE | Severe Adverse Event Reporting |Adverse Event
To Contact Us - [ Ссылка ]
For further information click here - [ Ссылка ]
Delve into the intricate world of adverse event evaluation with Episode 6 of our Pharmacovigilance Interview Q&A Series!
Join Dr. Neema Bisht as she elucidates the distinctions between seriousness and severity, unraveling the complexities of the CTCAE grading system.
Gain invaluable insights into reporting severe adverse events and enhancing your pharmacovigilance acumen.
Don't miss out on this enlightening discussion!
Mail: connect@careerinpharma.com
Website: [ Ссылка ]
To Join our Masterclass: [ Ссылка ]
Join our Telegram Channel: [ Ссылка ]
Follow us on Instagram: [ Ссылка ]
Facebook Group: [ Ссылка ]
LinkedIn: [ Ссылка ]
Timestamps
00:00 - Introduction
00:48 - Seriousness vs Severity
01:53 - Severity of adverse event
02:57 - Seriousness of adverse event
03:49 - CTCAE Grading System
06:48 - Conclusion
Ещё видео!